Nawar Latif

1.4k total citations
101 papers, 774 citations indexed

About

Nawar Latif is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Nawar Latif has authored 101 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Reproductive Medicine, 52 papers in Obstetrics and Gynecology and 25 papers in Surgery. Recurrent topics in Nawar Latif's work include Ovarian cancer diagnosis and treatment (52 papers), Endometrial and Cervical Cancer Treatments (51 papers) and Uterine Myomas and Treatments (24 papers). Nawar Latif is often cited by papers focused on Ovarian cancer diagnosis and treatment (52 papers), Endometrial and Cervical Cancer Treatments (51 papers) and Uterine Myomas and Treatments (24 papers). Nawar Latif collaborates with scholars based in United States, United Kingdom and Italy. Nawar Latif's co-authors include Emily Ko, Dimitrios Nasioudis, Ashley Haggerty, Robert Giuntoli, Mark A. Morgan, Lori Cory, Spyridon Mastroyannis, Sarah H. Kim, Robert A. Burger and Benjamin B. Albright and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

Nawar Latif

94 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nawar Latif United States 14 390 372 176 167 104 101 774
Alessandro Tropea Italy 18 269 0.7× 291 0.8× 350 2.0× 154 0.9× 137 1.3× 59 805
Berta Díaz‐Feijoó Spain 19 446 1.1× 766 2.1× 288 1.6× 150 0.9× 231 2.2× 92 1.0k
Gabriel Jaime Rendón-Pereira Colombia 13 303 0.8× 447 1.2× 295 1.7× 211 1.3× 345 3.3× 31 983
Reitan Ribeiro Brazil 14 766 2.0× 1.2k 3.3× 472 2.7× 281 1.7× 370 3.6× 67 1.6k
Stephanie L. Wethington United States 21 484 1.2× 554 1.5× 206 1.2× 307 1.8× 139 1.3× 67 1.0k
Ricardo dos Reis Brazil 22 701 1.8× 1.2k 3.2× 466 2.6× 259 1.6× 509 4.9× 98 1.7k
Roberto Tozzi Italy 21 915 2.3× 987 2.7× 596 3.4× 153 0.9× 104 1.0× 78 1.5k
Elisabeth Diver United States 16 338 0.9× 371 1.0× 181 1.0× 271 1.6× 84 0.8× 57 775
Geneviève Bouchard‐Fortier Canada 15 377 1.0× 437 1.2× 182 1.0× 117 0.7× 182 1.8× 54 712
Danielle Vicus Canada 18 475 1.2× 453 1.2× 218 1.2× 223 1.3× 233 2.2× 83 1.0k

Countries citing papers authored by Nawar Latif

Since Specialization
Citations

This map shows the geographic impact of Nawar Latif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nawar Latif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nawar Latif more than expected).

Fields of papers citing papers by Nawar Latif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nawar Latif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nawar Latif. The network helps show where Nawar Latif may publish in the future.

Co-authorship network of co-authors of Nawar Latif

This figure shows the co-authorship network connecting the top 25 collaborators of Nawar Latif. A scholar is included among the top collaborators of Nawar Latif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nawar Latif. Nawar Latif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Minyoung, Emily Ko, Robert Giuntoli, et al.. (2025). Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit. International Journal of Gynecological Cancer. 36(2). 102824–102824.
2.
Nasioudis, Dimitrios, et al.. (2025). Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. International Journal of Gynecological Cancer. 35(6). 101897–101897.
3.
Nasioudis, Dimitrios, Stefan Gysler, Emily Ko, et al.. (2024). Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers. 16(11). 2051–2051. 1 indexed citations
4.
Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations
5.
Johannesson, Liza, Elliott G. Richards, Jessica Walter, et al.. (2023). The First 5 Years of Uterus Transplant in the US—A Report From the United States Uterus Transplant Consortium. Obstetrical & Gynecological Survey. 78(3). 139–141. 8 indexed citations
7.
Nasioudis, Dimitrios, Jin-Hee Oh, Emily Ko, et al.. (2022). Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion. International Journal of Gynecological Cancer. 32(9). 1129–1134. 3 indexed citations
8.
Cory, Lori, Colleen Brensinger, Robert A. Burger, et al.. (2022). Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma. Gynecologic Oncology Reports. 39. 100930–100930. 3 indexed citations
9.
Neal, Donald, Mohammed Dany, Marilyn T. Wan, et al.. (2022). Interdisciplinary Management of Extramammary Paget's Disease Using Mohs Micrographic Surgery With Frozen Section Cytokeratin-7 Immunostains. Urology. 166. 164–169. 3 indexed citations
10.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2022). Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer. 32(11). 1355–1360. 5 indexed citations
11.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Nawar Latif, et al.. (2021). Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Surgical Oncology. 38. 101589–101589. 11 indexed citations
12.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2021). Quality of oncologic care and outcomes of patients with endometrial cancer managed at minority-serving hospitals. Gynecologic Oncology. 162. S35–S35. 1 indexed citations
13.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2021). Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival. Gynecologic Oncology. 162. S124–S124. 2 indexed citations
14.
Nasioudis, Dimitrios, Ashley Haggerty, Robert Giuntoli, et al.. (2020). Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer. Surgical Oncology. 34. 7–12. 8 indexed citations
15.
Nasioudis, Dimitrios, Emily Ko, Ashley Haggerty, et al.. (2020). Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy. Gynecologic Oncology. 157(3). 613–618. 3 indexed citations
16.
Albright, Benjamin B., Dimitrios Nasioudis, Stuart Craig, et al.. (2020). Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. American Journal of Obstetrics and Gynecology. 224(2). 195.e1–195.e17. 26 indexed citations
17.
Brensinger, Colleen, Nawar Latif, Robert Giuntoli, et al.. (2020). Assessment of poor functional status and post-acute care needs following primary ovarian cancer debulking surgery. International Journal of Gynecological Cancer. 30(2). 227–232. 5 indexed citations
18.
Nasioudis, Dimitrios, Nawar Latif, Fiona Simpkins, et al.. (2019). Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base. Gynecologic Oncology. 156(2). 315–319. 7 indexed citations
19.
Nasioudis, Dimitrios, et al.. (2018). Disparities in the use of fertility-sparing surgery for early stage cervical cancer. Fertility and Sterility. 110(4). e175–e176. 1 indexed citations
20.
Latif, Nawar, Xiaochen Zhang, Lorraine T. Dean, et al.. (2017). Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. International Journal of Gynecological Cancer. 27(3). 581–587. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026